.Creating value through therapeutic innovation

News...... 15 June, 2009  NicOx : additional 24-hour blood pressure results for naproxcinod presented at the EuropeanMeeting on Hypertension  12 June, 2009  NicOx presents naproxcinod results in several posters at EULAR  09 June, 2009  NicOx publishes results of the ZEST phase 2 study for naproxcinod  Shareholder meetings of NicOx convened on second call for June 17, 2009 Presentation given by Michele Garufi, Chairman & CEO, and Eric Castaldi, Chief Financial Officer, at the Shareholder meetings   19 May, 2009  NicOx presents phase 3 quality of life data for naproxcinod at ISPOR 13 May, 2009  NicOx reports first quarter 2009 financial results